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A B S T R A C T
Purpose: The aim was to investigate the prevalence of eating disorders and its relation to pregnancy and
delivery complications in childbearing women with epilepsy (WWE).
Method: This study is based on The Norwegian Mother and Child Cohort Study (MoBa) linked to the
Medical Birth Registry of Norway. Epilepsy was reported in 706 pregnancies. The remaining cohort
(n = 106,511) served as the reference group. Eating disorders were diagnosed using DSM-IV criteria
adjusted for pregnancy. The risk of preeclampsia, gestational hypertension, diabetes and weight gain
during pregnancy as well as delivery outcome (small for gestational age, large for gestational age,
ponderal index, low APGAR score, small head circumference) were calculated as odds ratios (ORs) with
95% conﬁdence intervals (CIs) adjusted for maternal age, smoking, parity and socioeconomic factors.
Results: Pregnant WWE were signiﬁcantly more likely to have binge eating disorder (6.5% vs. 4.7%,
p < 0.05). WWE and comorbid eating disorders had signiﬁcantly more preeclampsia (7.9% vs. 3.7%,
p < 0.05), peripartum depression and/or anxiety (40.4% vs. 17.8%, p < 0.001) and operative delivery
(38.2% vs. 23.5%, p < 0.001) than the reference group without epilepsy or eating disorders. After
adjustment for confounders, a signiﬁcantly increased risk of operative delivery (OR 1.96, CI 1.26–3.05)
and peripartum depression and/or anxiety (OR 2.17, CI 1.40–3.36) was demonstrated.
Conclusion: Eating disorders in WWE contribute to the increased risk of pregnancy and delivery
complications. Health personnel should be aware of eating disorders in WWE and refer them for
treatment before pregnancy.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Antiepileptic drug (AED) treatment is used by 0.2–0.7% of
pregnant women [1,2]. Several obstetrical complications such as
preeclampsia, gestational hypertension, caesarian delivery, con-
genital malformations and low birth weight occur more frequently
in these women than in women without epilepsy [3]. Adverse birth
outcomes in women with epilepsy (WWE) are believed to be* Corresponding author at: Department of Neurology, Haukeland University
Hospital, Jonas Lies vei 65, N-5021 Bergen, Norway. Tel.: +47 95729056;
fax: +47 55975164.
E-mail addresses: kolstadeivind@gmail.com, evid@helse-bergen.no (E. Kolstad).
http://dx.doi.org/10.1016/j.seizure.2015.02.014
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights remediated by AED use, although the exact mechanisms of action
and the role of confounding factors remain unclear. Comorbid
eating disorders (ED) are an unexplored potential contributor to
pregnancy complications in WWE.
Using data from The Norwegian Mother and Child Cohort Study
(MoBa), Reiter et al. [4] found an increased life time prevalence of
self-reported, unspeciﬁed ED in pregnant WWE. Rai et al. also
found an increased frequency of ED (OR 2.9) in non-pregnant
persons with epilepsy [5].
Adverse pregnancy outcomes are more frequent in women with
ED, especially for the subgroup with binge eating disorder (BED)
[6]. Women with BED deliver babies that are large for gestational
age and have an increased risk of caesarian section. An increased
rate of miscarriages has been noted in both anorexia nervosa (AN)served.
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increased risk of stillbirth, low birth weight, low Apgar scores,
breech presentation, lower weight-for-length offspring trajecto-
ries and cleft lip and palate [9,6,10].
As both epilepsy and ED increase the risk of complications
during pregnancy and delivery, we investigated the prevalence and
subtypes of this combination during pregnancy, and estimated
possible impacts of ED in epilepsy on pregnancy and birth outcome
in WWE.
2. Materials and methods
The Norwegian Mother and Child Cohort Study (MoBa) is a
prospective population-based pregnancy cohort study con-
ducted by the Norwegian Institute of Public Health. Participants
were recruited from all over Norway from 1999 to 2008. The
women consented to participation in 40.6% of the pregnancies.
The cohort now includes 114,500 children, 95,200 mothers and
75,200 fathers. The response rate was 45% [11]. The women
received standardized questionnaires addressing information
on maternal epilepsy, psychiatric symptoms and socioeconomic
status. The MoBa database is linked to the Medical Birth Registry
of Norway that contains information on pregnancy and delivery
complications.
The MoBa database comprises 706 pregnancies in women with
epilepsy and 106,508 pregnancies in women without epilepsy.
Information concerning ED was available for 73,171 pregnancies.
The MoBa epilepsy cohort has been validated [12,13].
The women answered questions in accordance with DSM-IV
criteria for AN, BN and BED. The questions were slightly adjusted
due to the cohort being pregnant, amenorrhea was not required in
AN. We also evaluated ‘‘impaired bodyimage’’ deﬁned as fulﬁlling
the AN criteria, except for amenorrhea and low BMI criteria. The
frequency of fasting, use of laxantia and vomiting during
pregnancy was investigated. The rates of ED in the women
without epilepsy in the MoBa study have been validated [14].
We investigated the relationship between epilepsy and any
type of ED (except for impaired body image) and hypertension
during pregnancy, diabetes during pregnancy, preeclampsia,
peripartum depression and/or anxiety [15], excessive pregnancy
weight gain (>16 kg), operative deliveries (caesarian section, use
of vacuum or forceps), small for gestational age (<10th percentile),
large for gestational age (>10th percentile), small head circumfer-
ence (<10th percentile) [16], low Apgar score (<7 after 5 min) andTable 1
Weight, BMI and eating disorders in women with and without epilepsy.
Reference
n = 106,508
Weight (SD) 68.0 (12.9) 
BMI (SD) 24.0 (4.3) 
Impaired bodyimagee 2356 (3.6%) 
BEDa pre-pregnancyc 3165 (3.3%) 
BED during pregnancyd 4298 (4.7%) 
Bulimia pre-pregnancyc 1747 (1.7%) 
Bulimia during pregnancyd 466 (0.5%) 
Use of laxantia during pregnancyd,f 79 (0.1%) 
Fasting during pregnancyd,f 60 (0.1%) 
Vomiting during pregnancyd,f 392 (0.4%) 
a BED = binge eating disorder.
b AED = antiepileptic drugs.
c Pre-pregnancy = last 6 months before pregnancy.
d During pregnancy = gestation week 17–19.
e Impaired bodyimage = DSM-IV criteria for anorexia nervosa, but amenorrhea and B
f Use of laxantia, fasting or vomiting at least once a week with the purpose of contr
*p < 0.05; **p < 0.01; ***p < 0.001 vs. the reference group.ponderal index (weight/length3, <10th percentile and >90th
percentile). Neonatologists have preferentially used the ponderal
index rather than small for gestational age as an indicator of
nutritional status in the child, and the variable is a predictor of
neonatal disease [17].
IBM SPSS Statistics version 21 was used. We investigated group
differences using Student’s t test and Pearson’s x2 test (Fisher’s
exact test if any cross table cell had an expected count < 5). Binary
logistic regression was used to estimate the odds ratio (OR) with
95% conﬁdence interval (CI) for pregnancy and delivery complica-
tions adjusted for the confounding factors maternal age, parity,
smoking and socioeconomic factors (low household income, low
education or being a single mother).
The study was approved by the Regional Ethical Committee in
Western Norway.
3. Results
WWE in the MoBa cohort more frequently had lower
educational attainment, low income, single parenting, and were
younger than women without epilepsy [15]. They also had
signiﬁcantly higher weight and BMI than the reference group
(Table 1).
There was a signiﬁcantly increased rate of BED and ‘‘impaired
body image’’ during pregnancy in WWE compared to women
without epilepsy (Table 1). ‘‘Impaired body image’’ was signiﬁ-
cantly increased in both women using AED monotherapy (6.9%,
p < 0.05, n = 266) and polytherapy (9.4%, p < 0.05, n = 72), as
compared with the reference group (3.6%). No difference in
prevalence was found for bulimia or anorexia before or during
pregnancy.
WWE and comorbid ED had signiﬁcantly more often pre-
eclampsia (7.9% vs. 3.7%), peripartum depression and/or anxiety
(40.4% vs. 17.8%) and operative delivery (38.2% vs. 23.5%) than
women without epilepsy and no ED (Fig. 1). WWE and comorbid
ED had more peripartum depression and/or anxiety than WWE
without ED (40.4% vs. 24.2%, p < 0.01). No confounding factors
were considered in this analysis.
After adjusting for confounding factors, WWE and comorbid ED
had a signiﬁcantly greater risk of peripartum depression and/or
anxiety (OR = 2.17, CI 1.4–3.4, p < 0.001) and operative delivery
(OR = 1.96, CI 1.3–3.0, p < 0.01, Fig. 2). After additional adjustment
for AED use, the risk of operative delivery was no longer
signiﬁcantly higher (OR 1.35, CI 0.7–2.5, p < 0.35).Epilepsy
n = 706
No AEDb
n = 367
AED
n = 338
69.5 (13.7)** 69.2 (13.0)* 69.7 (14.3)*
24.7 (4.6)*** 24.6 (4.5) 24.8 (4.8)
30 (6.1%)** 13 (4.9%) 17 (7.5%)**
30 (4.5%) 13 (3.7%) 17 (5.3%)*
41 (6.5%)* 21 (6.3%) 20 (6.6%)
7 (1.0%) 4 (1.1%) 3 (0.9%)
1 (0.1%) 1 (0.3%) 0 (0%)
0 0 0
2 (0.3%)* 1 (0.3%) 1 (0.3%)
4 (0.7%) 2 (0.7%) 2 (0.6%)
MI < 18.5 were not required.
olling body weight.
Fig. 1. Pregnancy and delivery complications (plot A) and birth outcome (plot B) according to a diagnosis of epilepsy and/or eating disorders. Signiﬁcance levels are marked
with *, compared with the reference group without eating disorder. W = with, wo = without.
Fig. 2. Complications during pregnancy, delivery and birth outcome. WWE and ED (grey markers) and WWE and no ED (black markers) compared with the reference group (all
other women in MoBa). Risk of complications during pregnancy (plot A) and risk of adverse birth outcome (plot B). The estimates are adjusted for parity, maternal age,
smoking and socioeconomic factors. Depression/anx = peripartum depression and/or anxiety. Op. delivery = caesarian section, use of vacuum or forceps. PI = ponderal index.
SGA/LGA = small/large for gestational age. SGA head = small for gestational age head circumference. Low Apgar: <7 after 5 min.
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Pregnant WWE have an increased risk of binge eating disorder.
WWE and comorbid ED more often had operative deliveries and
pregnancy related depression and/or anxiety.
In contrast with other psychiatric disorders, ED has rarely been
studied in epilepsy. Using DSM-IV criteria we found slightly higher
rates of ED than reported in non-pregnant patients with epilepsy (5%
point prevalence) [5]. Possibly, earlier estimates of ED in epilepsy did
not include BED. In women without epilepsy, BED is the most
common type of ED during pregnancy [18]. As reproductive health is
negatively affected by ED [19], a lower rate of ED in pregnant than in
non-pregnant WWE is expected. This is supported by Reiter et al.
who found an increased life-time prevalence of unspeciﬁed self-
reported ED in pregnant WWE compared with other women in the
same study sample (4.8% vs. 2.9%), but very few reported having such
disorders during pregnancy (0.4% vs. 0.3%). Similarly, unspeciﬁed EDhas been found in only 0.8% of women without epilepsy after
delivery [20].
The subgroup of WWE with ED had a numerically higher risk
than the rest of the epilepsy cohort for the majority of pregnancy
and delivery complications investigated. However, the power to
ﬁnd an ED related difference surpassed 60% only for peripartum
depression and/or anxiety as well as operative deliveries. Our
results were probably driven by BED. This disorder increases the
risk for complications during pregnancy and delivery, and adverse
birth outcome, such as higher birth weight babies, higher risk of
large for gestational age and caesarian section than the referent [6].
There are several explanations as to why WWE with ED have
more pregnancy complications. Women with ED are more likely to
smoke during pregnancy [18]; this is why we adjusted for this in
our binary logistic regression model. Comorbid anxiety, depression
and excessive weight gain may be associated with adverse effects
on pregnancies and birth outcome [21,22]. Furthermore, the use of
AEDs is a risk factor for pregnancy complications [3,12], and partly
E. Kolstad et al. / Seizure 28 (2015) 81–8484mediated the risk for operative deliveries in WWE and ED in
our data.
The prospective design of the MoBa study minimized reporting
bias. The participation rate of 40.6% at ﬁrst assessment is expected
for population-based studies [23]. A study investigating selection
bias found that epilepsy prevalence was similar in the MoBa study
and in the general Norwegian population [24].
5. Conclusion
The increased risk for complications in WWE with ED during
pregnancy with possible adverse health effects for both mother
and child should be considered and minimized in consultations
both before and during pregnancy.
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